Literature DB >> 24746881

Inhibition of peripheral FAAH depresses activities of bladder mechanosensitive nerve fibers of the rat.

Naoki Aizawa1, Petter Hedlund2, Claudius Füllhase3, Hiroki Ito1, Yukio Homma4, Yasuhiko Igawa5.   

Abstract

PURPOSE: FAAH degrades endocannabinoids and fatty acid amides. FAAH inhibition reduces micturition frequency and counteracts bladder overactivity in rats. We studied the effects of the peripherally active selective FAAH inhibitor URB937, and the CB1 and CB2 receptor antagonists rimonabant and SR144528, respectively, on single unit afferent activity of primary bladder afferents in rats.
MATERIALS AND METHODS: Female Sprague Dawley® rats were anesthetized. Single unit afferent activity of Aδ or C-fibers from the L6 dorsal roots was recorded during bladder filling before and after URB937 administration with or without rimonabant or SR144528. Drugs (1 mg/kg) were given intravenously. FAAH, CB1 and CB2 expression, and expression of the sensory marker CGRP in the L6 dorsal root ganglion were compared by immunofluorescence.
RESULTS: A total of 102 single afferent fibers (48 Aδ and 54 C-fibers) were isolated from 57 rats. URB937 decreased single unit afferent activity of C-fibers to a mean ± SEM of 78% ± 9% and of Aδ-fibers to a mean of 67% ± 7% while increasing bladder compliance to a mean of 116% ± 3%. The effects of URB937 on single unit afferent activity and bladder compliance were counteracted by rimonabant or SR144528. Rimonabant increased single unit afferent activity of each fiber type but SR144528 affected only Aδ-fiber activity. CGRP positive L6 dorsal root ganglion neurons showed strong FAAH, CB1 and CB2 staining.
CONCLUSIONS: To our knowledge we report for the first time that inhibiting peripheral FAAH depresses the Aδ and C-fiber activity of primary bladder afferents via CB1 and CB2 receptors. CB antagonists alone exerted facilitatory effects on single unit afferent activity during bladder filling in rats. The endocannabinoid system may be involved in physiological control of micturition as regulators of afferent signals.
Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  afferent; cannabinoid; endocannabinoids; nerves; receptors; urinary bladder; urination

Mesh:

Substances:

Year:  2014        PMID: 24746881     DOI: 10.1016/j.juro.2014.04.008

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats.

Authors:  Marsha Ritter Jones; Zun-Yi Wang; Dale E Bjorling
Journal:  Am J Clin Exp Urol       Date:  2015-04-25

Review 2.  The endocannabinoid system - a target for the treatment of LUTS?

Authors:  Petter Hedlund; Christian Gratzke
Journal:  Nat Rev Urol       Date:  2016-07-05       Impact factor: 14.432

Review 3.  Report and Research Agenda of the American Geriatrics Society and National Institute on Aging Bedside-to-Bench Conference on Urinary Incontinence in Older Adults: A Translational Research Agenda for a Complex Geriatric Syndrome.

Authors:  Camille P Vaughan; Alayne D Markland; Phillip P Smith; Kathryn L Burgio; George A Kuchel
Journal:  J Am Geriatr Soc       Date:  2017-12-04       Impact factor: 5.562

4.  Attenuation of cystitis and pain sensation in mice lacking fatty acid amide hydrolase.

Authors:  Zun-Yi Wang; Peiqing Wang; Cecilia J Hillard; Dale E Bjorling
Journal:  J Mol Neurosci       Date:  2014-11-06       Impact factor: 3.444

5.  Activation of cannabinoid receptor 1 inhibits increased bladder activity induced by nerve growth factor.

Authors:  Zun-Yi Wang; Peiqing Wang; Dale E Bjorling
Journal:  Neurosci Lett       Date:  2015-01-06       Impact factor: 3.046

6.  Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats.

Authors:  Ana Charrua; Rita Matos; Raquel Oliveira; Tim Marczylo; Istvan Nagy; Francisco Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-09-15       Impact factor: 3.000

Review 7.  Muro-Neuro-Urodynamics; a Review of the Functional Assessment of Mouse Lower Urinary Tract Function.

Authors:  Hiroki Ito; Anthony E Pickering; Yasuhiko Igawa; Anthony J Kanai; Christopher H Fry; Marcus J Drake
Journal:  Front Physiol       Date:  2017-02-06       Impact factor: 4.566

Review 8.  Endocannabinoids in Bladder Sensory Mechanisms in Health and Diseases.

Authors:  Stewart Christie; Simon Brookes; Vladimir Zagorodnyuk
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

9.  Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors.

Authors:  Igor Blaha; Paz Recio; María Pilar Martínez; María Elvira López-Oliva; Ana S F Ribeiro; Ángel Agis-Torres; Ana Cristina Martínez; Sara Benedito; Albino García-Sacristán; Vítor S Fernandes; Medardo Hernández
Journal:  PLoS One       Date:  2016-06-10       Impact factor: 3.240

Review 10.  Potential of Endocannabinoids to Control Bladder Pain.

Authors:  Dale E Bjorling; Zun-Yi Wang
Journal:  Front Syst Neurosci       Date:  2018-05-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.